PMID: 15220702Jun 29, 2004Paper

Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Enrico GirardiICoNA Behavioural Epidemiology Study Group

Abstract

Ensuring timely access to care for persons with HIV is an important public health goal. To identify factors associated with delayed presentation to medical care after testing HIV-positive or with late HIV testing, we studied 968 patients at their first HIV care visit, enrolled in a multicenter study in Italy from 1997-2000. Patients completed a questionnaire on HIV-testing history, sexual behavior, and drug use behavior. Delayed presenters were patients with >6 months between their first HIV-positive test and presentation for HIV care; late testers were patients with CD4 count < 200 /mm or clinically defined AIDS at their first HIV-positive test. Among the study patients, 255 (26.3%) were delayed presenters, and 280 (28.9%) were late testers. In multinomial logistic regression analysis, injection drug use significantly increased (odds ratio [OR]= 5.04) the probability of delayed presentation but reduced (OR = 0.55) the chance of late testing. A previous HIV-negative test was associated with a reduced risk of both delayed presentation (OR = 0.39) and late testing (OR = 0.36). Unemployment was positively associated with delayed presentation and increasing age with late testing, whereas HIV counseling at the time of first positive...Continue Reading

References

Jul 1, 1995·AIDS·K A PhillipsT J Coates
Apr 29, 1998·Archives of Internal Medicine·J H SametR Hingson
Aug 26, 1998·JAMA : the Journal of the American Medical Association·S A StrathdeeR S Hogg
Sep 23, 1998·European Journal of Epidemiology·V PuroG Ippolito
Dec 22, 1999·AIDS·R O ValdiserriG R West
Jul 18, 2000·American Journal of Public Health·M D SteinM A Schuster
Mar 21, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·F H GalvanR N Bluthenthal
Apr 5, 2001·Sexually Transmitted Infections·E GirardiUNKNOWN ICONA Study Group
Feb 1, 1996·AIDS Patient Care and STDs·J R IckovicsJ Rodin
Jul 10, 2001·American Journal of Public Health·R S JanssenK M De Cock
Jul 27, 2001·Drug and Alcohol Dependence·A R KnowltonC A Latkin
Nov 2, 2001·AIDS Patient Care and STDs·J MilbergD Parham
Feb 28, 2002·American Journal of Public Health·Jeffrey Levi
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Patrick G YeniPaul A Volberding
Jan 7, 2003·AIDS Patient Care and STDs·Gregory M LucasRichard D Moore
Feb 7, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel KleinUNKNOWN Consortium for HIV/AIDS Interregional Research

❮ Previous
Next ❯

Citations

Aug 17, 2012·AIDS Care·Benjamin H BaldersonSheryl Catz
Dec 29, 2006·AIDS Patient Care and STDs·Cyrille DelpierreUNKNOWN NADIS Group
Aug 8, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine R LeskoMichael J Mugavero
May 12, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Suely H TuboiBryan E Shepherd
Jun 13, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Isaac M KigoziJudith A Hahn
Jul 2, 2008·HIV Medicine·T CoenenS Matic
Apr 26, 2012·BMC Infectious Diseases·Alexandre GrangeiroJulio Cesar Rodrigues Pereira
Mar 30, 2013·BMC Public Health·Laura CamoniUNKNOWN regional representatives of the HIV Surveillance System
Jul 7, 2011·AIDS Research and Therapy·Patricia Garcia de OlallaUNKNOWN HIV Surveillance Group
May 26, 2007·International Journal of STD & AIDS·Cyrille DelpierreUNKNOWN VESPA Study Group
Oct 19, 2013·PLoS Medicine·Amanda MocroftUNKNOWN Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Oct 27, 2010·PloS One·Yazdan YazdanpanahA David Paltiel
May 5, 2011·The American Journal of Tropical Medicine and Hygiene·Mathieu NacherPierre Couppié
Aug 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ann M DennisJoseph J Eron
Sep 13, 2013·AIDS and Behavior·Gabriela Paz-BaileyJames D Heffelfinger
Jan 6, 2012·AIDS and Behavior·Abraham MukoloKenneth A Wallston
May 15, 2010·AIDS Care·Biru YangLu-Yu Hwang
Dec 2, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·UNKNOWN Late presenters working group in COHERE in EuroCoordOle Kirk
Jun 15, 2010·Enfermedades infecciosas y microbiología clínica·Jesús OlivaMercedes Díez
Mar 19, 2013·Mycoses·Lisandra Serra DasmascenoTerezinha do Menino Jesus Silva Leitão

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.